Doctor’s Guide -- SAN DIEGO -- September 14, 2010 -- High hospital readmission rates associated with the newer continuous flow left ventricular assist device (LVAD) may limit its application to patients with advanced heart failure -- despite the fact that it has largely replaced the pulsatile version, researchers said here at the 13th Annual Scientific Meeting of the Heart Failure Society of America (HFSA).
